Article Information
History
- May 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michael Wells1,2,
- Karam P. Asmaro1,2,
- Thais S. Sabedot1,2,
- Tathiane M. Malta1,2,
- Maritza S. Mosella1,2,
- Kevin Nelson1,
- James Snyder1,2,
- Ana deCarvalho1,
- Abir Mukherjee3,
- Dhananjay Chitale3,
- Adam Robin1,
- Mark Rosenblum1,
- Thomas Mikkelsen1,
- Laila M. Poisson4,
- Ian Y. Lee1,
- Tobias Walbert1,
- Arti Bhan6,
- Steven Kalkanis1,
- Jack Rock1,
- Houtan Noushmehr1,2 and
- Ana Valeria Castro1,2,*
- 1Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA
- 2Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, MI, USA
- 3Department of Pathology, Henry Ford Health System, Detroit, MI, USA
- 4Department of Biostatistics, Henry Ford Health System, Detroit, MI, USA
- 5Department of Radiology, Henry Ford Health System, Detroit, MI, USA
- 6Department of Endocrinology, Henry Ford Health System, Detroit, MI, USA
- ↵*Corresponding author
Ana Valeria B. Castro, MD, PhD Department of Neurosurgery Hermelin Brain Tumor Center; Henry Ford Health System 2799 West Grand Blvd, E&R 3096 Detroit, MI, 48202 acastro1{at}hfhs.org
Posted May 30, 2020.
Detection of Circulating Tumor-specific DNA Methylation Markers in the Blood of Patients with Pituitary Tumors
